SCHEDULE 13G

AN2 Therapeutics, Inc.

Common Stock · CUSIP: 037326105

Event date: 2025-05-28

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Coastlands Capital LP

  Shares: 2,815,900.00 · Class: 9.3%

• Coastlands Capital Partners LP

  Shares: 2,815,900.00 · Class: 9.3%

• Coastlands Capital GP LLC

  Shares: 2,815,900.00 · Class: 9.3%

• Coastlands Capital LLC

  Shares: 2,815,900.00 · Class: 9.3%

• Matthew D. Perry

  Shares: 2,815,900.00 · Class: 9.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.